These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31634934)

  • 1. Neuroimaging Spectrum of Inherited Neurotransmitter Disorders.
    Lim YT; Mankad K; Kinali M; Tan AP
    Neuropediatrics; 2020 Feb; 51(1):6-21. PubMed ID: 31634934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is new for monoamine neurotransmitter disorders?
    Marecos C; Ng J; Kurian MA
    J Inherit Metab Dis; 2014 Jul; 37(4):619-26. PubMed ID: 24696406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid investigations for neurometabolic disorders.
    Hoffmann GF; Surtees RA; Wevers RA
    Neuropediatrics; 1998 Apr; 29(2):59-71. PubMed ID: 9638660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain MR patterns in inherited disorders of monoamine neurotransmitters: An analysis of 70 patients.
    Kuseyri Hübschmann O; Mohr A; Friedman J; Manti F; Horvath G; Cortès-Saladelafont E; Mercimek-Andrews S; Yildiz Y; Pons R; Kulhánek J; Oppebøen M; Koht JA; Podzamczer-Valls I; Domingo-Jimenez R; Ibáñez S; Alcoverro-Fortuny O; Gómez-Alemany T; de Castro P; Alfonsi C; Zafeiriou DI; López-Laso E; Guder P; Santer R; Honzík T; Hoffmann GF; Garbade SF; Sivri HS; Leuzzi V; Jeltsch K; García-Cazorla A; Opladen T; ; Harting I
    J Inherit Metab Dis; 2021 Jul; 44(4):1070-1082. PubMed ID: 33443316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia.
    Hoffmann GF; Assmann B; Bräutigam C; Dionisi-Vici C; Häussler M; de Klerk JB; Naumann M; Steenbergen-Spanjers GC; Strassburg HM; Wevers RA
    Ann Neurol; 2003; 54 Suppl 6():S56-65. PubMed ID: 12891655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The monoamine neurotransmitter disorders: an expanding range of neurological syndromes.
    Kurian MA; Gissen P; Smith M; Heales S; Clayton PT
    Lancet Neurol; 2011 Aug; 10(8):721-33. PubMed ID: 21777827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of neurotransmitter disorders.
    Pearl PL; Hartka TR; Taylor J
    Curr Treat Options Neurol; 2006 Nov; 8(6):441-50. PubMed ID: 17032564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine neurotransmitter disorders--clinical advances and future perspectives.
    Ng J; Papandreou A; Heales SJ; Kurian MA
    Nat Rev Neurol; 2015 Oct; 11(10):567-84. PubMed ID: 26392380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Movement Disorders in Treatable Inborn Errors of Metabolism.
    Ebrahimi-Fakhari D; Van Karnebeek C; Münchau A
    Mov Disord; 2019 May; 34(5):598-613. PubMed ID: 30557456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When do we need to perform a diagnostic lumbar puncture for neurometabolic diseases? Positive yield and retrospective analysis from a tertiary center.
    Haliloğlu G; Vezir E; Baydar L; Onol S; Sivri S; Coşkun T; Topçu M
    Turk J Pediatr; 2012; 54(1):52-8. PubMed ID: 22397043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epilepsy in inherited neurotransmitter disorders: Spotlights on pathophysiology and clinical management.
    Mastrangelo M
    Metab Brain Dis; 2021 Jan; 36(1):29-43. PubMed ID: 33095372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain neurotransmitters in glycine encephalopathy.
    Kish SJ; Dixon LM; Burnham WM; Perry TL; Becker L; Cheng J; Chang LJ; Rebbetoy M
    Ann Neurol; 1988 Sep; 24(3):458-61. PubMed ID: 2906530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal Fluid Biogenic Monoamine Analysis for Diagnosis of Primary Neurotransmitter Disorders.
    Lokhande RV; Dherai AJ; Bhagure GR; Udani VP; Kulkarni SD; Ashavaid TF
    Indian J Pediatr; 2021 Dec; 88(12):1241-1243. PubMed ID: 34541626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of computed tomography, magnetic resonance imaging, and localized 1H magnetic resonance spectroscopy in Canavan's disease: a case report.
    Marks HG; Caro PA; Wang ZY; Detre JA; Bogdan AR; Gusnard DA; Zimmerman RA
    Ann Neurol; 1991 Jul; 30(1):106-10. PubMed ID: 1929222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disorders of amino acid metabolism associated with epilepsy.
    Lee WT
    Brain Dev; 2011 Oct; 33(9):745-52. PubMed ID: 21803516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The International Working Group on Neurotransmitter related Disorders (iNTD): A worldwide research project focused on primary and secondary neurotransmitter disorders.
    Opladen T; Cortès-Saladelafont E; Mastrangelo M; Horvath G; Pons R; Lopez-Laso E; Fernández-Ramos JA; Honzik T; Pearson T; Friedman J; Scholl-Bürgi S; Wassenberg T; Jung-Klawitter S; Kuseyri O; Jeltsch K; Kurian MA; Garcia-Cazorla À;
    Mol Genet Metab Rep; 2016 Dec; 9():61-66. PubMed ID: 27830117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical aspects of the disorders of GABA metabolism in children.
    Pearl PL; Gibson KM
    Curr Opin Neurol; 2004 Apr; 17(2):107-13. PubMed ID: 15021235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric neurotransmitter diseases.
    Pearl PL; Wallis DD; Gibson KM
    Curr Neurol Neurosci Rep; 2004 Mar; 4(2):147-52. PubMed ID: 14984687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches for diagnosis and treatment in neurotransmitter disorders of childhood.
    Havalı C; Dorum S; Ekici A; Görükmez Ö
    Metab Brain Dis; 2021 Dec; 36(8):2255-2262. PubMed ID: 34550503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creatine biosynthesis and transport in health and disease.
    Joncquel-Chevalier Curt M; Voicu PM; Fontaine M; Dessein AF; Porchet N; Mention-Mulliez K; Dobbelaere D; Soto-Ares G; Cheillan D; Vamecq J
    Biochimie; 2015 Dec; 119():146-65. PubMed ID: 26542286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.